DEA'S 'DRUG WAR' TARGETS PAIN DOCTORS, PATIENTS

by William Fisher

(IPS) -- Wheelchair -bound multiple sclerosis patient Richard Paey is serving 25 years in a Florida prison for "trafficking" a half gram of OxyContin, even though the prosecutor concedes that Paey never sold any of his medications. In prison, he now receives more painkilling drugs than he was convicted of having.

Dr. William Hurwitz, a pioneering pain physician, was tried and convicted of violating the Controlled Substances Act -- which is intended to curb the illicit use of drugs -- and is serving a 25-year term in federal prison. He was also fined $2 million.

These are but two of hundreds of cases in which, in its zeal to stamp out illegal drug use, the U.S. Drug Enforcement Administration (DEA) is cracking down on doctors who prescribe medications to relieve chronic pain, and the patients who depend on these drugs to live normal lives.

Hundreds of physicians have been put on trial for charges ranging from health insurance fraud to drug distribution, even to manslaughter and murder for over-prescribing prescription narcotics. Investigators have also seized doctors' homes, offices and bank accounts, leaving them with no resources for their defense.

In March 2004, DEA administrator Karen Tandy told Congress her drug warriors have "been successful in addressing OxyContin diversion as evidenced by a reduction in the rate of increase of OxyContin prescriptions being written and a leveling-off of OxyContin sales."

Drug diversion means the diversion of legal drugs for illicit purposes. Prescription drug abuse accounts for almost 30 percent of the overall drug problem in the United States, representing a close challenge to cocaine addiction. Sometimes these diverted prescription drugs end up for sale on the street, where they reap large profits for traffickers.

Starting in the mid-1990s, and ratcheting up in 2001, the DEA -- part of the U.S. Justice Department -- has been leading an aggressive effort to eradicate the illegal "diversion" of certain prescription painkillers. A particular target has been OxyContin, one of a class of drugs known as opioids, which was aggressively marketed by its manufacturer, Purdue Pharma.

In 2001, the DEA launched a campaign called the "OxyContin Action Plan." The DEA says the plan is necessary due to increasing abuse of prescription drugs, particularly by youth. The agency, which has teamed up with state and local authorities, typically employs law enforcement methods developed in the government's "War on Drugs," including aggressive undercover investigation, asset forfeiture and informers. It says its goal is to stop violations of the Controlled Substances Law.

But critics charge that the DEA has focused too narrowly on doctors, exacerbating the already widespread problem of untreated or under-treated pain. As a result, well-meaning doctors are finding themselves subject to costly, potentially career-ending investigations. Several doctors and many of their patients have already been sent to prison.

The DEA maintains that only "criminal doctors" are being targeted, and that its efforts to prevent the sale of prescribed medications have no effect on the legitimate treatment of pain.

The pain-management community disagrees. Authorities say the DEA program reportedly is having a chilling effect on physicians, who are leaving their pain management specialties for safer practices, and on their patients, many of whom literally cannot function without medication. The Village Voice newspaper reports that medical schools are now advising students to avoid pain management practice altogether.

Ironically, the DEA crackdown comes at a time when the medical profession knows more than ever about how to treat the chronic pain that makes life intolerable -- sometimes impossible -- for the estimated 50 million to 70 million Americans who live in chronic disabling pain.

Until about 20 years ago, the medical profession knew little about pain management. Today, pain management has become a recognized medical specialty, and it is estimated that there are some 5,000 pain management doctors practicing in the U.S.

The DEA's programs also come at a time when there are more effective pain-killing drugs on the market and when the Internet makes it easier than ever to obtain them.

The DEA's dilemma is separating legitimate prescribers and users from drug dealers. And the agency's task is made more difficult not only by its zeal, but by the fact that those investigating and prosecuting are not doctors but lawyers and law enforcement agents.

Before he was ever charged with a crime, Hurwitz recommended that the DEA "suspend current prosecutions against physicians who treat pain unless and until a review by a panel of nationally recognized experts in medical pain management has found that there is an absence of good faith by the physician."

The Association of American Physicians and Surgeons, in a letter to the judge in the Hurwitz case, charged he was convicted on the basis of "false expert testimony," which it described as "egregious."

The Hurwitz situation is not isolated. Throughout the U.S., physicians have been prosecuted, jailed, or have lost their licenses to practice medicine. In addition to Hurwitz, Dr. Ronald McIver is serving 30 years, Dr. Freddie Williams is serving life, and Dr. James Graves received a 62-plus-year sentence for diversion in 2002.

According to Ronald Libby, a professor of political science at the University of North Florida who has become an authority on the subject, "Many doctors have been convicted and almost no one has been acquitted."

He told IPS, "Most attorneys tell their clients to cop a plea and not fight it in court."

Richard Paey was convicted of fraudulently submitting multiple copies of opioid prescriptions to treat chronic pain. He was in New Jersey where his doctor treated him, but then moved to Florida where he was unable to find a physician to write prescriptions to treat his pain.

Frightened by what they term a "brutal display of executive power," most doctors, including those in the field of pain management, have simply abandoned this sickest and most vulnerable segment of the population. Patients suffering from mild to moderate pain and requiring low dosages of opioids may still find care, but those patients with high dosage requirements are increasingly shut out of care altogether.

The DEA claims it investigates less than 1 percent of physicians who prescribe OxyContin or other drugs covered by the Controlled Substances Act. The agency reported arresting 34 doctors out of 963,385 registered doctors in 2003 for selling opioids to addicts or drug dealers for money, sex or favors. That is less than 0.001 percent of the total number of licensed doctors, the DEA said.

But critics dispute that figure. Libby told IPS, "In 2001, the DEA carried (out) 861 investigations of doctors. If we use this figure instead of 34 arrests it means that more than 17 percent of the roughly 5,000 doctors who treat pain patients were investigated," he said.

To calm its critics, the DEA commissioned several pain specialists to work with federal officials to create guidelines for physicians who treat pain with opioids. These guidelines were posted on the agency's Web site, and most doctors were led to believe that following the recommendations would keep them safe from prosecution.

But that understanding didn't last long. Late last year the guidelines were taken off the DEA's Web site. The agency claimed it wasn't bound by any standards or practices when it came to determining what physicians it would investigate.

Dr. Alexander DeLuca, a member of the American Academy of Preventive Health and a board member of the Pain Relief Network, told IPS, "Relations between physicians and the DEA have probably never been worse in modern times."

He added, "Law enforcement does not deserve a place at the table where physicians, social workers, and politicians of good will need to meet to deal with drug use and pain problems as public health, not criminal, matters."